Friday, January 07, 2011 1:12:57 PM
If is quacks like a duck and walks like a duck, it is probably a duck. There is too much evidence by the company, by the RegSHO data and by the 'fail to deliver' data provided by the SEC to say shorting isn't occuring.
Management's analysis indicates that certain short-term factors have combined to interrupt normal market forces from properly pricing the stock. These factors include:
1. Transitioning of stockholder base in tandem with the Company's new direction and new management into medical manufacturing, consulting, distribution, and online distribution;
2. Year-end tax selling;
3. Short selling and management's refusal to deal with short sellers through sales of stock, etc.;
4. New management's opposition to paid stock promotions which tend to produce stock price peaks and valleys instead of stable increases.
Management strongly believes that its philosophy of concentrating on business fundamentals is the only long-term solution to improving and maintaining a representative stock price.
IMO
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM